Indices Grind Highe...
Health Care: Drugs
Novartis AG (NVS: NYSE)
$56.38 0.23 | 0.41%
02/09/12 - 01:10 PM ET
1.49M / 2.42M
Vol / Avg. Vol:56.50 / 56.15
Open / Prev. Close:56.24 - 56.56
Today's Range:51.60 - 64.82
52 Wk Range:-1.78%
Performance YTD:TheStreet Rating:
Portfolios with NVS
- Portfolio NameUser Type
- ContributorLarge-Cap Dividend Stocks t...
- User2012 performers
- ContributorHighest-Yielding Drug Stocks
- Contributor7 Pharma Buys for 2012
- ContributorCredit Suisse's 14 Ultimate...
- Usergeeman1001 Portfolio 1
- ProIrving Kahn - Kahn Brothers
- ContributorDividend Stars Portfolio
- UserReal Investment Portfolio
- UserKarleldelandes
Latest NVS Headlines from TheStreet
- Novartis AG's CEO Discusses Q4 2011 Results - Earnings Call Transcript 01.25.12 | 04:01 pm
- Novartis AG's CEO Discusses Q4 2011 Results - Earnings Call Transcript 01.25.12 | 04:01 pm
- Business Events Scheduled For The Coming Week 01.20.12 | 02:01 pm
- Stocks End Lower on Eurozone Downgrades 01.13.12 | 05:01 pm
- They Just Don't Get Novartis! 01.13.12 | 11:01 am
- They Just Don't Get Novartis!
01.13.12 | 10:01 am - Apple Store, Novartis: Hot Trends 01.13.12 | 10:01 am
- Stock Futures Tick Lower on JPMorgan Disappointment 01.13.12 | 08:01 am
- Stocks to Watch: JPMorgan, Bank of America (Update 1) 01.13.12 | 08:01 am
- Apple Store, Novartis: Hot Trends 01.13.12 | 08:01 am
Press Releases for NVS
- IBM Launches University Competition To Combat Growth Of Non-Communicable Diseases - PR Newswire 10.07.11 | 03:10 pm
- ITG Healthcare Market Research Study Finds XGEVA On Track To Be Top-Prescribed Drug For Prevention Of SREs In Cancer Patients - PR Newswire 07.28.11 | 08:07 am
- ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva Is Poised To Steal Significant Share From Novartis' Zometa; Physicians Still On The Fence About Dendreon's Provenge - PR Newswire 03.22.11 | 04:03 pm
Partner Headlines for NVS
- Analysts' 5 Favorite Stocks With Strong Dividend Growth - Seeking Alpha 02.09.12 | 09:02 am
- An Income-Growth Portfolio For 2012: 4%+ Yield, Dividend Growth And Lower Beta - Seeking Alpha 02.02.12 | 08:02 am
- The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche - Press Releases - Zacks 02.01.12 | 09:02 am
- 6 Recession-Proof Dividend Stocks - Seeking Alpha 01.31.12 | 06:01 am
- The Zacks Analyst Blog Highlights: J. C. Penney, Kohl's, Macy's, Novartis and Sanofi - Press Releases - Zacks 01.30.12 | 09:01 am
- 8 High Dividend Stocks With Strong Fundamentals - Seeking Alpha 01.27.12 | 09:01 am
- Zacks Bull and Bear of the Day Highlights: DaVita, Hhgregg, Mylan, Teva Pharmaceutical and Novartis - Press Releases - Zacks 01.25.12 | 09:01 am
- Neutral on Biogen - Analyst Blog - Zacks 01.20.12 | 05:01 pm
- Keeping An Eye On Isis - Seeking Alpha 01.13.12 | 07:01 pm
- Biosimilars: The Next Big Thing - Analyst Blog - Zacks 01.13.12 | 05:01 pm
